West Family Investments, Inc. Incyte Corp Transaction History

West Family Investments, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 03, 2023	SELL	$70.23 - $86.01 $3,160 - $3,870	-45 Reduced 1.18%	3,769 $272,000
Q4 2022 Feb 08, 2023	BUY	$67.18 - $84.11 $23,580 - $29,522	351 Added 10.14%	3,814 $306,000
Q3 2022 Nov 04, 2022	BUY	$66.18 - $82.86 $45,267 - $56,676	684 Added 24.61%	3,463 $231,000
Q2 2022 Aug 12, 2022	BUY	$66.18 - $83.18 $794 - $998	12 Added 0.43%	2,779 $211,000
Q1 2022 May 13, 2022	BUY	$66.02 - $79.71 $182,677 - $220,557	2,767 New	2,767 $0

645

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16.3B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of West Family Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on West Family Investments, Inc. with notifications on news.